Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Expression Pattern of Axin2 During Chicken Development


Canonical Wnt-signalling is well understood and has been extensively described in many developmental processes. The regulation of this signalling pathway is of outstanding relevance for proper development of the vertebrate and invertebrate embryo. Axin2 provides a negative-feedback-loop in the canonical Wnt-pathway, being a target gene and a negative regulator. Here we provide a detailed analysis of the expression pattern in the development of the chicken embryo. By performing in-situ hybridization on chicken embryos from stage HH 04+ to HH 32 we detected a temporally and spatially restricted dynamic expression of Axin2. In particular, data about the expression of Axin2 mRNA in early embryogenesis, somites, neural tube, limbs, kidney and eyes was obtained.


Axin2 (also called Axil or Conductin) is a homologue of Axin protein. It shares approximately 45% of amino acids with Axin [1, 2]. The Axin protein houses four highly conserved functional domains throughout the species [35]. The N-terminal RGS-domain has been found to interact with the tumour suppressor gene adenomatous polyposis coli (APC) [1, 6]. Central in the Axin protein, binding sites for β-catenin and for the glycogen-synthase kinase 3 beta (GSK-3β) were described [4]. At the C-terminal region, the DIX-domain is located that resembles the sequence of a DIX—domain in dishevelled protein (Dvl) and promotes its interaction with Axin [7]. At its C-terminus, Axin also interacts with the protein phosphatase 2A (PP2A) [3, 8, 9]. Being responsible for the degradation of the downstream canonical Wnt-signalling pathway molecule β-catenin, Axin and Axin2 function as negative regulators of the canonical Wnt-signalling pathway [5, 1012]. The Wnt-signalling pathway is one of the best elucidated signalling pathways. First, the canonical Wnt-pathway was described, followed by at least two non-canonical pathways. The pathway of planar cell polarity (PCP) and the Wnt/Ca2+-pathway are referred to as non-canonical pathways [1315]. These are described to establish orientation in epithelia (PCP) and to play a role in early embryonic ventral patterning (Wnt/Ca2+-pathway) ([16] for review). Canonical and non-canonical Wnt-signalling are known to be enmeshed with each other, as their members partially contribute to more than one pathway [17, 18] and several Wnt ligands were described to activate both canonical and non-canonical pathways [1922]. However, in this study, only the canonical pathway is of relevance, constituting a venue for the Axin family [10]. Central to canonical Wnt-signalling stands the transcriptional activator β-catenin. When entering the nucleus, β-catenin can displace transcriptional repressors such as Groucho [23] from the TCF/LEF transcription factor, which now activates the transcription of target genes ([24] for review). In the unstimulated cell, a multi-protein complex mediates the degradation of β-catenin via the ubiquitin proteasome pathway [25, 26]. For this purpose, β-catenin is phosphorylated by one of the two kinases of the complex, GSK-3β or the casein kinase 1 (CK1).Axin acts as a central scaffold protein in the degradation complex by binding and thus bringing together all important components [3]. For this purpose, Axin and Axin2 contain highly conserved regions. GSK-3β phosphorylates β-catenin, which subsequently is ubiquitinated by the E3 ubiquitinase βTrCP and degraded by a proteasome [4, 27]. GSK-3β further phosphorylates Axin itself, leading to stabilization of its interaction with β-catenin [4]. APC and one of the relevant receptors in Wnt pathway, the low density lipoprotein related receptor LRP 5/6 are also known to be substrates of GSK-3β [28, 29]. Although GSK-3β is capable of phosphorylating β-catenin alone, Axin unites both proteins, facilitating and significantly accelerating this process [30]. Finally, this process represses β-catenin in the cytoplasm to a level that prohibits its access to the nucleus. In the presence of APC, the turnover of β-catenin increases [6, 31]. Previous studies suggest a role for APC in the recruitment of several β-catenin molecules to the environment of the destruction complex [5, 32, 33]. Upon arrival of Wnt-ligands, they bind to the seven-pass transmembrane receptor Frizzled and to its co-receptor, the low density lipoprotein related protein receptor (LRP) 5 or 6 [3436]. This heterodimeric complex binds Dvl at the cytoplasmatic tail of Fz [37] and initiates the recruitment of Axin and kinases (Gsk3b or Ck1) to the membrane, mediating the dissociation of the β-catenin-destruction complex [29, 38, 39]. Several studies have been performed in order to elucidate the exact molecular scenario after Wnt-binding. For instance, Wnt was described to induce Dvl, that is thought to recruit Axin-bound GSK-3β to the membrane, where the latter phosphorylates LRP 5/6 and as a consequence dissociates from Axin [29, 40]. The phosphorylation of LRP 5/6 can equally be achieved by CK1 [39, 41]. Axin priorly was dephosphorylated by another member of the β-catenin degradation complex, the protein phosphatase 1 (PP1) [42, 43]. Unphosphorylated Axin releases β-catenin [30, 40] and easily binds to LRP 5/6. Binding of Axin to Dvl that is connected to the cytoplasmatic tail of Frizzled, is proposed to facilitate this initial recruitment [27]. Previous studies have further proposed a model for the formation of so called signalosomes, built from multiple associated LRP/Axin complexes [44]. As a result of the dissociation from the β-catenin-destruction complex, β-catenin is not degraded any more, cytoplasmatic levels rapidly rise and it enters the nucleus [37]. A special function for Axin2 was found, when discovering its transcriptional dependence on TCF/LEF motive [45]. Axin2 expression therefore is initiated by canonical Wnt-signalling and provides a negative-feedback loop [27, 37, 45]. As this study aims to emphasize the relevance of Axin2 in regulating the Wnt-signalling pathway, it is important to mention the state of the art regarding the role of canonical Wnt-pathway in development and in disease. During development, canonical Wnt-signalling is described to be required for proper posterior axis formation and for the formation of the head [4648]. Moreover, Wnt-signalling is known to be indispensable in the developing central and peripheral nervous system [49]. It is described to be involved to the segmentation clock during somitogenesis [50] and in the development of several other structures and organs, such as the limbs, the kidney, the gastrointestinal system, the sensory organs and the lungs ([37, 49] for review). In the adult, deregulation of the Wnt pathway cause several cancers and Wnt-signalling is required for stem cell self renewal [51, 52]. The regulation of Wnt-signalling via Axin and Axin2 impacts embryonic development and health in the adult, as described by many studies. Axin mutant mice failed to survive [11, 53] and display severe developmental defects. Mice with homozygous mutations in Axin2 developed a secondary caudal body axis [11] and exhibited malformations of the skull due to premature fusion of cranial structures [54]. This malformation is an equivalent to the human disease craniosynostosis, that is described to develop on the basis of Axin2 mutations [55]. Another developmental defect associated with Axin2 abnormalities in mice and human is familial tooth agenesis and oligodontia [56, 56, 57]. Further, Axin is related to hepatocellular cancer [58, 59], ovarian cancers [60] and to medulloblastomas [61]. Axin2 mutations play a secondary role in familal adenomatous poliposis coli (FAP), when the causal mutation is not situated in APC and because proper function of APC requires Axin [62, 63]. Predisposition to colorectal cancer, when carrying mutations in Axin2 is described [58, 63]. Shedding similar functions than Axin, Axin2 was previously tested on its functional redundancy [54]. Axin2 was shown to be able to at least partially compensate for mutated Axin when expressed in the respective cells. Axin however, is expressed in small amounts in all embryonic tissues, while Axin2 expression was described to be restricted and dynamic during mouse development [11, 45]. Interestingly, Axin was described to be the limiting factor in Wnt regulation, referring to its low cytoplasmatic levels [64]. Axin2 on the other hand, is highly expressed, suggesting an extensive role for Axin2 regulation in certain tissues. This observation, together with the fact that Axin2 is a target of Wnt-signalling, indicates the importance of Axin2 mediated negative regulation in certain tissues. In this study, we demonstrate the dynamic expression pattern of Axin2 in the development of the chick.

Materials and Methods


Fertilized eggs of Gallus gallus domesticus were incubated at 37°C and 80% relative humidity. Eggs were provided by a local breeder (Sörries-Trockels Vermehrungszucht). Staging was performed according to Hamburger and Hamilton [65].

The obtained chicken embryos were isolated, fixed in 4% PFA for at least 24h. For description and analysis of the expression pattern of Axin2 during chicken development, chicken embryos in developmental stages HH 04 to HH 32 were proceeded in in-situ hybridization.

Whole mount in-situ hybridization

Whole mount in-situ hybridization was performed as previously described [66], using cAxin2 riboprobe for detection of Axin2 transcripts in all embryonic tissue.

Generation of a riboprobe for in-situ hybridization.

The probe for cAxin2 in-situ hybridization was generated from a pCMS-EGFP plasmid containing a full length Axin2 coding sequence. It was restricted using EcoRV and SmaI to obtain a 835bp fragment binding from bp926 to bp1788 on Axin2 mRNA (NCBI Reference Sequence: NC_006105.4). The purified fragment was blunted and cloned to pJET1.2/blunt Cloning Vector. From here, the fragment was excised using XbaI and XhoI and ligated to pBluescript II KS+ Vector. The obtained plasmid was suitable for generating a riboprobe in in vitro transcription.



The embryos were embedded in 2, 5 − 4% agarose gel and sectioned with Vibratome (Leica VT 1000 S) to 50–80μm. Sections were collected and covered with cover slips and Aquatex (Merck).


In-situ hybridized chicken embryos were embedded in Leica tissue freezing medium®and frozen with liquid nitrogen. Obtained blocks were sectioned with Leica CM3050 S cryo-stat. Sections were collected on slides, dried and covered using Aquatex (Merck).

Ethic statement.

According to German legislation, the use of embryonic vertebrates in an animal experiment needs approval only if the animal is in the last third of its embryonic development. In the case of chicken, this means that experiments done on animals before embryonic day 14 (E14) are not regarded as an animal experiment by the Tierschutzgesetz, and therefore, do not need approval or governmental permission.

The chicken embryos sacrificed for this work were between developmental stages HH+04 (E1) and HH32 (E7.5). All embryos were sacrificed at the end of the study by opening the shell and tearing the allantois and amnion with forceps. Thereafter, the embryos were immersed in 4% PFA/PBS solution for fixation. No permits were required for the described study, which complied with all relevant regulations.

Results and discussion

0.1 Expression pattern of cAxin2 during early chicken embryogenesis

After whole mount in-situ hybridization, a dynamic expression pattern of Axin2 was found from stages HH 04 to 32. In early embryogenesis, Axin2 expression was observed in the primitive streak (ps)(Fig 1, A black arrow, B, C, D) and in the Hensen’s node (hn)(Fig 1, B red arrow, C red arrow, D, E). Additionally, the head fold (hf) heavily expresses Axin2 from stage HH 07+ onwards (Fig 1, B, C black arrows). During further development, in stage HH 10, Axin2 transcripts were detectable in the Hensen′s node (hn), posterior presomitic mesoderm (psm) (Fig 1, E) and medially in the freshly segmented paraxial mesoderm (dml-dorso-medial lip) (Fig 1, E.1 red arrow). Transversal sections were performed to analyse the expression of Axin2 during early embryogenesis in detail. They present gastrulation and neurulation processes, where the maturation can be observed in a cranial to caudal axis. The green bars in the whole mount specimens indicate the sectioning level. Sections of HH stage 08 (Fig 1, C.1, C.2, C.3) show the caudally regressing primitive streak (ps) with the primitive groove (pg). The primitive folds (pf) of the ectoderm and the developing mesoderm underlying the primitive groove (pg) express Axin2 (Fig 1, C.1, C.2, C.3). Further, the transversal section of the head fold (hf) in HH stage 08 (C.4) shows intense expression of Axin2 in medial parts, facing towards the lumen of the anterior neuropore. In HH 09, during the primary neurulation process, cranially to Hensen’s node (hn) (Fig 1, D, D.1, D.2), only little Axin2 is expressed in the neural groove (ng) (Fig 1, D.1, D.2) and in the elongating notochord (nc) (Fig 1, D.1 and D.2). At this stage the head folds (hf) at mid-brain (mb) level have converged (Fig 1, D.3) and Axin2 expression is increased in the medial neural folds. In Fig 1, E.2, E.3, E.4 and E.5 (HH 10), the segmental plate mesoderm (spm) is formed, as the neural folds (nf) extend distally to form the neural tube (nt). Axin2 is expressed in the neural groove (ng) and in the notochord (nc)(Fig 1, E.4, E.5). At HH stage 10 more cranially, first somites (so) are shaped in the segmental plate mesoderm (Fig 1, E.2, E.3), as the neural folds (nf) fuse to form the neural tube (nt). In sections E.6 to E.8 (Fig 1), the development of the caudally shifted Hensen’s node (hn) is depicted. Axin2 expression is restricted to the central Hensen’s node (Fig 1, E.6, E.7, E.8) expanding towards the ventral axial mesoderm (am). In picture E.6 (Fig 1), the prechordal mesoderm (pcm) is heavily stained for Axin2.

Fig 1. Expression of cAxin2 in stages HH 04+ to HH 10.

Overviews and transversal sections of chicken embryos. Green bars in overviews (C, D, E) indicate sectioning level. (A) HH 04+: Axin2 transcripts in ps (black arrow). (B) HH 07+: expression intensified in ps, hn(red arrow) and hf (black arrow). (C) HH 08: expression in hf (black arrow), hn (red arrow) and ps. (C.1) Axin2 expression in pf and pg. (C.2) intense staining in the pf. (C.3) expression thickened ectoderm as a first step of neurulation. (C.4) transcripts in the most medial inner epithelium of the hf. (D) HH 09: expression in hn, faintly in the psm and in the mb. (D.1, D.2) expression in the ng and in the nc. (D.3) strong expression in the medial layer of the hf. (E) HH 10: strong Axin2 expression in hn and psm, as in the mb. (E.1) higher magnification of the so and nt shows expression in the medial so, the dml. (E.2) faint staining in medio-dorsal epithelium of the early so and in the developing nt. (E.3) transcripts rarely detectable in the nf prior to closing. (E.4) expression of Axin2 in the nc and in the annealing nf. (E.5) expression in the centre of the nf and in the nc. (E.6, E.7, E.8) upheaval of the nf in the distal-most hn. (E.6) expression in the centre of the future nt and in the pcm. (E.7, E.8) transcripts in the folding neuroectoderm expanding towards the am. ps-primitive streak, hn-Hensen′s node, hf-head fold, pf-primitive folds, pg-primitive groove, psm-presomitic mesoderm, mb-mid-brain, ng-neural groove, nc-notochord, so-somites, nt-neural tube, nf-neural fold, spm-segmental plate mesoderm, pcm-prechordal mesoderm, am-axial mesoderm.

By stage HH 11, the expression of Axin2 in the dorso-medial lip (dml) appears (Fig 2, A, A.1 black arrows). This expression intensifies as the somites mature (Fig 2, HH 14: B, black arrow and HH 15: C, C.1 black arrows). Additionally, the posterior neuropore (pnp) is intensively stained for Axin2 (Fig 2, A, B, C). Regarding the head of the depicted embryos in Fig 2, Axin2 expression is visible predominantly in the mid-brain (mb)(Fig 2, A, B.1, C white arrow). During secondary neurulation, which describes the elongation of the neural tube (nt) into the tail bud, Axin2 is expressed centrally in the tail bud mesoderm (tbm)(Fig 2, C.2, C.3, C.4) in HH 15 and ventrally in the recently formed secondary neural tube (snt) and secondary notochord (snc)(Fig 2, C.2).

Fig 2. Expression of cAxin2 in stages HH 11 to HH 15.

Overviews (A, B, C) and transversal sections of chicken embryos. Green bars in overviews indicate sectioning level (C). (A) HH 11: Axin2 expression in the head, pnp, nt and (A, A.1) dml of the so (black arrow). (B) HH 14: strong expression in the dml (black arrow). (B.1) transversal section through the head at mid-brain level with transcripts in the medial head fold in in the adjacent neighbouring mesenchyme (black arrow). (C) HH 15: Axin2 expression in the brain (white arrow), the dml (C.1 black arrow) and in the pnp. (C.2) expression in the snc and in the ventral snt. (C.3, C.4) Axin2 expression in the tbm. (C.5) section through head and neck with expression of Axin2 in the oc, the neighbouring hb and the ov. pnp-posterior neuropore, nt-neural tube, dml-dorso-medial lip, so-somites, snc-secondary notochord, snt-secondary neural tube, tbm-tail bud mesoderm, oc-otic cup, hb-hind-brain, ov-optic vesicle.

In stage HH 14 at mid-brain level (Fig 2, B.1), the anterior neuropore has closed and Axin2 expression has shifted to a patch in the ventral mesoderm, flanking the mid-brain (mb)(Fig 2, B.1 black arrow). In HH stage 15, Axin2 expression is detectable in the developing sensory organs, eye and ear, for the first time (Fig 2, C.5). Axin2 mRNA was detected in the otic cup (oc)(Fig 2, C.5) and adjacent hind-brain (hb), as well as in the out-pocketing optic vesicle (ov)(Fig 2, C.5). The optic vesicle (ov) forms laterally from the prosencephalon, where Axin2 is transcribed in the medial wall.

Previous studies have investigated the role of Wnt-signalling during gastrulation, neurulation, axis- and head formation. In the early patterning events of the vertebrate body, canonical Wnt-signalling is believed to first act as dorsalizing and later as posteriorizing signal [67, 68]. In concordance to that, several Wnt-mutant mice exhibit truncated posterior axis, lost tail formation and disturbed somitogenesis [69, 70]. Experiments in chicken and Xenopus resulted in axis duplication and disturbed head formation after Wnt overexpression [71]. Proper formation of the head requires Wnt inhibition in the anterior embryonic tissue [7274]. Ectopic expression of Wnt inhibitors was found to induce notochord formation [75]. The examination of Axin knockouts revealed its function in ventralizing the respective tissue and in inhibiting posterior axis formation [11]. Furthermore, Axin loss of function in Xenopus resulted in disturbed closure of neural folds, head folds and the duplication of the allantois [76]. These findings together with the our new observed expression of Axin2 during chicken embryogenesis support the idea that appropriate regulation Wnt-signalling via Axin2 influences body patterning, axis elongation and head formation. The expression of several Wnts in the chicken primitive streak and Hensen’s node reinforce this hypothesis [77].

0.2 Expression pattern of cAxin2 in stages HH 17 to 32

At HH stage 17, the chicken limb buds (lb) are distinguishable, expressing Axin2 mRNA from their onset (Fig 3, A red arrows). During the rapid outgrowth of the limb buds (lb) the Axin2 expression increases (Fig 3, HH 19: C, HH 20: D.1, HH 21: E.3, HH 22: F.2). The apical ectodermal ridge (aer) is notably stained (Fig 3, D.1 white arrow, E.3 black arrowhead, F.2 black arrow). In somites (so), Axin2 expression shifts from the medial somite to the intersomitic furrow (isf)(Fig 3, HH 21: E.1 white arrow; HH 22: F, F.2 white arrows). After whole mount in-situ hybridization, the neural tube (nt) is stained for Axin2 in two longitudinal stripes, at first weakly (Fig 3, HH 19: C.1, HH 20: D.2 black arrowhead), then stronger (Fig 3, HH 21: E.1 black arrowhead, HH 22: F.1 black arrowhead). Moreover, the mesenchyme of the sprouting tail bud (tb) expresses Axin2 (Fig 3, HH 17: A, HH 19: C.3 black arrowhead, HH 22: F.4 red arrow). As well as at other expression sites, Axin2 transcription relatively increases during maturation of the respective tissue or organ. At the head region, Axin2 is expressed in the otic vesicle (ov)(Fig 3, HH 17: A black arrow; HH 19: C.2 white arrow; HH 21: E.2 black arrowhead). Furthermore, the branchial arches (ba) are specifically stained after Axin2 in-situ hybridization (Fig 3, HH 19: C.2 black arrow, HH 21: E.2, HH 22: F.3). Moreover, the brain vesicles express Axin2.

Fig 3. Expression pattern of cAxin2 from HH stage 17 to 22.

(A) HH 17 embryo with Axin2 expression in the brain, lb (red arrows), tail and ov (black arrow). (A.1) dorsal view: expression in the dml (white arrow). (B) HH 18: more prominent staining in the lb and in the ba. (C, C.1, C.2 & C.3) HH 19: Axin2 transcripts in the nt(C.1) and dml (C.1, white arrow), in lb (C, C.1), in ov (C.2, white arrow), ba (C.2, black arrow) and in the tip of the tail (C.3, black arrow). (D, D.1, D.2) HH 20: similar expression of cAxin2. (D.1) the wing bud expresses Axin2, white arrow: aer. (D.2) dorsal view: prominent expression in nt (black arrowhead) and isf(white arrow). (E, E.1, E.2, E.3) HH 21: Transcripts in the tip of the tail (E, black arrowhead), in nt and so(E.1), in the otic anlage (E.2, black arrowhead) and in the developing lb (E.3). (F, F.1, F.2, F.3 and F.4) HH 22: consecutive expression of Axin2 mRNA in ba (F, black arrow; F.3), nt (F.1, black arrow), isf (F, white arrow, F.2, white arrow) and tail (F.4, red arrow). lb-limb buds, ov-otic vesicle, dml-dorso medial lip, ba-branchial arches, nt-neural tube, aer-apical ectodermal ridge, isf-intersomitic furrow, so-somites.

HH 23 to 29 embryos (Fig 4) express Axin2 in similar regions, compared to the earlier developmental stages, with little changes. Axin2 is expressed in brain and otic vesicle (ov) throughout these stages (Fig 4, HH 24: B.1 white arrow). In addition, the branchial arches (ba) show intense staining (Fig 4, HH 24: B.1), which becomes restricted during development and predominantly was observed on the protuberances of the mandibular (Fig 4, HH 27: E black arrowhead, HH 28: F white arrow) and maxillary arch, respectively (Fig 4, HH 29: G white arrow). The expression pattern in the neural tube (nt) changes from two longitudinal lines (as described above) to one central line (Fig 4, HH 26: D.3; HH 27: E.1 white arrows). Another expression site of Axin2 is presented in Fig 3, picture E. Here, the white arrow indicates an Axin2 expression in the facial development. Axin2 is still expressed in the limbs (lb) by stage HH 26 (Fig 4, D.1). Here, it is notable that in further developed stages the future shoulder is heavily stained (Fig 4, HH 26: D.1, HH 28: F and HH 29: G red arrows). The interdigital zones, where programmed cell death occurs, express Axin2 (Fig 4, HH 28: F and HH 29: G black arrows). This observation was continuously found in the development of digits in later stages (Fig 4, HH 31: H black arrow and HH 32: I). Strong Axin2 expression is also visible in these older stages’ shoulders (Fig 4, HH 31: H and HH 32: I). The chicken external ear (ee) expresses Axin2 as well (Fig 4, HH 31: H and HH 32: I red arrows). Finally, Axin2 is expressed in the first rows of feather buds (fb) on the back of the farthest developed stages (Fig 4, HH 31: H, H.1 and HH 32: I.1 white arrows), as at the shoulders and hips. On the chicken eye, the developing scleral ossicles express Axin2 (Fig 4, HH 32: I white arrow).

Fig 4. Axin2 transcripts in chicken embryos from stage HH 23 to HH 32.

(A) HH 23: expression pattern resembles what is described in Fig 2. Limbs, inner ear, brain, eye, and tb express Axin2 (A). (B, B.1 & B.2) HH 24: Axin2 expression in the ov (B.1, white arrow) and ba (B.1), as well as in nt and isf(B.2, dorsal view). (C, C.1) HH 25: Axin2 is expressed at similar embryonic structures with little change. (D, D.1, D.2, D.3) HH 26: Axin2 expression in ba (D, black and red arrow; D.2), ov(D.2), lb(D.1), brain (D), eye (D), isf (D.3, white arrow) and nt (D.3). (E) HH27: Axin2 transcripts in the facial whilst (E, white arrow), in the ba (black arrows), as well as in lb. The dorsal view (E.1) expression in the nt (white arrow). Ba display specific staining for cAxin2 (HH 28: F & HH 29: G, white arrows). HH 28 and 29: intense expression in the embryonic shoulder (F & G, red arrows). Expression of Axin2 in the forming interdigital spaces (F & G, black arrows). (H, H.1) HH 31: expression of Axin2 mRNA in lb and apoptotic interdigital zones (H, black arrow), at the ee(H, red arrow) and in the fb(H & H.1, white arrows). (I, I.1) HH 32: Axin2 transcripts in the eye (I, white arrow), ee (I, red arrow) and in the fb (I.1, white arrow). lb-limb buds, ov-otic vesicle, ba-branchial arches, tb-tail bud, nt-neural tube, isf-intersomitic furrow, fb-feather buds, ee-external ear.

0.3 Axin2 expression during somitogenesis

In transversal sections of in-situ hybridized chicken embryos, Axin2 expression was found during somitic differentiation (Fig 5). Green bars in the whole mount specimens (A, B, C, D, E, F, G) indicate the levels, where the sections have been performed. In the segmented paraxial mesoderm, Axin2 is expressed in the epithelial somites and in the differentiating dermomyotome. At HH stage 15 transcripts are mainly detectable in the medial and medio-dorsal wall of the epithelial somites (Fig 5, A.1 black arrow). This expression gains intensity in stage HH 16 and 17 as the somite (so) maturates (Fig 5, B.1, C.3). More cranially in HH 17, where somites have maturated even further, deepithelialization of the somite (so) has begun (Fig 5, C.2). Axin2 expression is relatively strong in the remaining medio-dorsal epithelium (Fig 5, C.2 black arrow) and in the mesenchyme ventrally flanking the neural tube (nt)(Fig 5, C.2 red arrow). Further cranially, where the dermomyotome is almost completely formed (Fig 5, C.1), Axin2 expression was found in the most ventral parts of the forming dml of the dermomyotome (Fig 5, C.1 black arrow) and in a patch adjacent to the ventral neural tube (nt)(Fig 5, C.1 red arrow). In stage HH 19, when the dermomyotome is fully established, transcripts are visible in the ventrally facing margin of the dml, neighbouring the sclerotome (Fig 5, HH 19: D.1 black arrow). In HH stage 20, at limb level Axin2 expression is detectable also in the ventro-lateral lip (vll) (Fig 5, E.1 wing level). In further development, this expression gets restricted to the dorsal half of the dermomyotome (dm), the epaxial myotome and appears more faintly (Fig 5, E.2 interlimb level).

Fig 5. Axin2 expression during somitogenesis and in the developing neural tube.

Transversal sections: green bars in overviews indicate sectioning level. (A) HH 15, overview; (A.1) expression in medial epithelial so(black arrow) and faintly all over the nt. (B) HH 16, overview; (B.1) increased expression in the medial somitic epithelium. (C) HH 17, overview; (C.1) Axin2 in dml (black arrow), in the mesenchyme ventrally flanking the nt (red arrow) and predominantly in the dorsal nt. (C.2) Expression in dorso-medial somitic epithelium (black arrow), ventrally in the mesenchyme (red arrow) and all over the nt. (C.3) Expression in the medial epithelial so. (D) HH 19, overview; (D.1) expression in dml and nt; (D.2) expression restricted to dorsal nt (green arrow) and ventrally in the neighbouring tissue (red arrow). (E) HH 20, overview; (E.1) expression throughout the dm; (E.2) Axin2 transcripts in the dorsal nt (green arrow), in the ventro-medially adjacent mesenchyme (red arrow) and weakly in the dml. (F) HH 22, overview; (F.1) Axin2 in the dorsal-most nt (green arrow) and in the overlying ectoderm (black arrow). (G) HH27, overview; (G.1) Axin2 expression in rp, fp (red arrow), drg (black arrow) and subectodermal space (green arrow). (H.1, H.2, H.3) snt of the tail. (H.1) HH 24, faint expression in all parts of the snt; (H.2) HH 27, restricted and intensified expression in the dorsal snt and in overlying subectodermal space; (H.3) HH 28, Axin2 in dorsal most snt and subectodermal space. so-somite, nt-neural tube, dml-dorso medial lip, dm-dermomyotome, rp-roof plate, fp-floor plate, drg-dorsal root ganglion, snt-secondary neural tube.

In mice Axin2 expression was found to oscillate in the segmental plate mesoderm and to occupy a central role for the segmentation of the presomitic mesoderm [50, 78]. We were able to detect Axin2 expression in the posterior psm in chicken from stage HH 09 to HH 16 (Figs 1 and 3). In mice, the expression of Wnt-genes alternates with the expression of FGFs in the PSM [78], indicating a similar mechanism in chicken. Interestingly Axin2 mutant mice still undergo segmentation with slight to average deviation [55, 78]. Additionally, Axin2 transcripts were found during the maturation of the somites. In this process, a network of many different Wnt-molecules and other signals is described to play a role. The patterning of the somites is controlled by dorsalizing Wnt1 and Wnt3a from the dorsal neural tube [7981], such as Wnt6 from the overlying ectoderm [82]. Wnt11 was described to maintain the epithelial status of the dml, while Wnt6 from the ectoderm maintains the epithelial ventro-lateral lip (VLL) [83]. Additionally, it was found that Wnt1 and Wnt3a are required for the formation of the dml [81]. Axin2 expression in the dml and its progenitors (Fig 5) indicate a potential role in the proper development of the dml and the deriving dermis. This hypothesis is supported when regarding the expression of Axin2 in the dermal derived feather buds (Fig 4, H.1, I.1).

0.4 Expression pattern in the developing neural tube

Regarding the development of the neural tube, Axin2 is expressed from neurulation to the differentiated mature neural tube (nt)(Figs 2 and 5). In Fig 5, the maturation of the neural tube (nt) is depicted. First, Axin2 mRNA was detected in a sprinkled distribution all over the neural tube (nt)(Fig 5, HH 15: A.1, HH 16: B.1, HH 17: C.1 and HH 19: D.1), with an intensified region at the medio-dorsal neuroepithelium (Fig 5, HH 17: C.1, HH 19: D.1). More cranially in HH 19, this expression appears more intense at the dorsal third (Fig 5, D.2 green arrow), while faint sprinkled expression remains in the ventral half of the neural tube (nt)(Fig 5, D.2). By HH stage 20, predominantly the dorsal expression domain increases even more (Fig 5, E.2 green arrow). Further, the faint expression site in the neighbouring tissue at left an right ventral side of the neural tube (nt) expands dorsally (Fig 5, E.2 red arrow). When maturating, the neural tube (nt) expresses Axin2 strongly in the dorso-medial neuroepithelium (Fig 5, HH 22: F.1 green arrow). Additionally, Axin2 transcripts are found in the overlying ectoderm and the subectodermal mesenchyme flanking the dorsal neural tube (nt)(Fig 5, HH 22: F.1 black arrow). In HH 27, Axin2 expression was observed in the dorsal most part of the neural tube (nt) and in the roof- and floor plate (rp)(fp)(Fig 5, G.1). The black arrow in G.1 (Fig 5) reveals to the tip of the dorsal root ganglion (drg) that heavily expresses Axin2. Further, the dorsal ectoderm and subectodermal space overlying the neural tube (nt) are intensively stained (Fig 5, G.1 green arrow).

Axin2 transcripts were also found in secondary neurulation in the tail bud (Fig 2, C.2, C.3, C.4). After secondary neurulation, the differentiating secondary neural tube (snt) heavily expresses Axin2 (Fig 5, H.1, H.2, H.3). First, this expression is well distributed over the entire neuroepithelium (Fig 5, HH 24: H.1). During maturation, transcripts were observed in HH 27, (Fig 5, H.2) mainly in the dorsal half of the secondary neural tube (snt) as in the overlying subectodermal mesenchyme and ectoderm. By HH 28 the Axin2 is missing in the ventral two thirds of the secondary neural tube (snt), but is expressed intensively in the dorsal third, such as in the ectoderm and subectodermal mesenchyme (Fig 5, H.3).

During the development and maturation of the neural tube, the establishment of a dorso-ventral axis through ventralizing Shh activity versus dorsalizing Wnt-signals has been described [84, 85]. The main Wnt-genes expressed in the dorsal neural tube and roof plate are Wnt1 and Wnt3a [84, 86]. These promote neural proliferation [84, 87]. Therefore, after activation of dorsal Wnt-signalling in the chick, dorso-ventral patterning of the neural tube was perturbed and mitogenic activity of neural progenitors was increased [88]. Wnt1 and Wnt3a inhibition in mice, besides incomplete closure of the neural folds, displayed phenotypic alterations throughout the neural tube including partially absent basal-, roof- and floor plates [89]. In addition, Wnts have been identified to play a role in ventrally specified neural progenitors [86, 90]. The countless signalling molecules interacting with the Wnt-signalling pathway during neural tube maturation imply that Axin2 expression and its negative-feedback-loop in canonical Wnt-signalling impact this neural development and the basic molecular functions will be of special interest in future research.

0.5 Expression pattern of cAxin2 during limb development

Limb development in chicken starts from an out-bulged ridge of the somatic lateral plate mesoderm by stage HH 15. At HH stage 17 the wing bud heavily express Axin2 predominantly in the dorsal mesenchyme (Fig 6, A.1 black arrow). The hind-limb bud at the same stage is slightly further developed and transcripts of Axin2 are present in the thickened ectoderm, which gives rise to the apical ectodermal ridge (aer)(Fig 6, A.2), as well as at proximo-ventral margin of the lateral plate mesoderm (Fig 6, A.2 black arrow). In stages HH 18 to HH 20 Axin2 is expressed in the dorsal mesenchyme of the rapidly outgrowing limb buds (Fig 6, B.1, C.1, D.1, D.2). Moreover, the apical ectodermal ridge (aer) is heavily stained for Axin2 (Fig 6, B.1, C.1, D.1 black arrow, D.2). By stage HH 23, the transcripts in the dorsal mesenchyme are reduced, though the ectoderm and apical ectodermal ridge (aer) still express Axin2 (Fig 6, E.1 black arrow). This expression was is consistent in further developed stages (Fig 6, HH 25: F.1; HH 26: G.1; HH 27: H.1 black arrow; HH 28: I.1, I.2 and I.3). Moreover, when regarding the developing bones (bo) in HH stage 26 and 28, we verified Axin2 mRNA at the marginal perichondrium (Fig 6, G.1 and I.3 black arrows).

Fig 6. Expression of Axin2 in chicken limb development.

(A.1, wing bud, w) HH 17, strong expression of Axin2 in the limb, predominantly in the dorsal most part (black arrow). (A.2) The leg bud (l) shows less staining, a patch in the ventro-proximal tissue expresses Axin2 (black arrow). (B.1, leg bud) HH 18, transcripts in the dorsal mesenchyme and in the distal ectoderm. (C.1) HH 19, expression in the dorsal and most proximal mesenchyme of the wing bud. (HH 19, C.1; HH 20, D.1 black arrow; D.2) Axin2 expression aer. (C.1) HH 19 and (D.1) HH 20, Axin2 in dorsal subectodermal mesenchyme, in ectoderm and in the aer. (E.1, E.2) HH 23; (F.1) HH 25: Transcripts in the ectoderm and aer of the limb buds. (E.2–I.3) HH 23 to HH 28: the ectoderm expresses high levels of Axin2. (G.1) HH 26, black arrow; (I.3) HH 28, black arrow: the margins of the developing bo show transcripts of Axin2. aer-apical ectodermal ridge, bo-bones.

Several members of the Wnt family are expressed in the developing limb ([37] for review). The outgrowth of the limb bud is mediated by the apical ectodermal ridge (aer) [91]. Wnt genes are described to initiate the formation of the limb bud (Wnt2b) from the lateral plate mesoderm as well as the aer (Wnt3a) [92]. The aer in chicken expresses Wnt3a that, by initiating fibroblast growth factor (FGF) expression, mediates the rapid cell proliferation in the mesenchymal progress zone (PZ) underlying the aer [93]. Non-canonical Wnt7a is expressed in the dorsal ectoderm of the chicken limb, being responsible for dorsalization [94, 95]. Its expression site overlaps an additional expression site for Wnt3a in the ectoderm during early limb growth [96]. As Wnt7a target genes are expressed in the mesenchyme underlying the dorsal ectoderm, it was suggested that their signalling ranges as far as the target gene expression [97]. We postulate a similar distance of signalling for the canonical Wnt3a from early dorsal limb ectoderm as a source for early Axin2 expression in the dorsal limb mesenchyme. Mutations of Wnt3a and Wnt7a and FGFs in chicken embryo induced the expression of a gene responsible for a form of polydactyly in human, the Townes-Brock-Syndrome [98]. Later in the limb development, canonical Wnt-signalling is described to promote cell proliferation and the differentiation of connective tissue [99]. Axin2 expression in accordance to our results was reported in the perichondrium of mice [99]. By describing the expression of Axin2 in the chicken developing limb, we want to reveal its presumable function in regulating Wnt-signals that are involved in outgrowth, proliferation and differentiation.

0.6 Expression patten of Axin2 during chicken nephrogenesis

The kidney development in birds and mammals takes place in three generations of nephric precursors [100]. In this study, an Axin2 expression in mesonephric development is described (Fig 7). In stage HH 19 the mesonephric duct (md) at leg level faintly expresses Axin2 (Fig 7, A.1 black arrow). By HH 20 at interlimb level, the staining expands to the overlying coelomic epithelium (coe)(Fig 7, B.1 black arrow).

Fig 7. Expression of Axin2 in nephric duct.

Axin2 mRNA expression in the md (HH 19: A:1, leg level, black arrow; HH 20: B.1, interlimb level, black arrow and B.2, leg level; HH23: C.1, caudal interlimb level, black arrow). The overlying thickened ectoderm strongly expresses Axin2 from HH stage 20 (B.1 & B.2, black arrows). Pictures D.1 and E.1 demonstrate detectable transcripts in the cloacal ectoderm (HH 26: D.1, HH 28: E.1 black arrows). md-mesonephric duct.

At leg level in HH 20, intense Axin2 expression in the nephric duct (md-mesonephric duct) and coelomic epithelium (coe) is observed (Fig 7, B.2 black arrow). When further differentiating, transcription of Axin2 decreases, but is still detectable in mesonephric duct (md) and overlying coelomic epithelium (coe)(Fig 7, HH 23: C.1 black arrow). In addition, Fig 7 shows transversal sections of the cloaca, where Axin2 is expressed predominantly in the coelomic epithelium (Fig 7, D.1, E.1. black arrows).

The role of Wnt in the developing kidney has been extensively studied in the past. Wnt4 and Wnt9b were described to be expressed in the nephric duct and coeloemic epithelium [101103]. The initiation of tubulogenesis of the developing kidney requires canonical Wnt4 and Wnt9b signals from the nephric duct [101, 102]. Later in development both Wnt-ligands were described to act through the PCP and the Ca2+-dependent pathway as well [104107]. As the Wnt-ligands partially activate different intracellular responses in the course of kidney development, the research faces a challenging aim in understanding this network. In Xenopus a model mediating the switch from canonical to non-canonical Wnt-signalling during nephrogenesis was proposed [108, 109]. However, canonical Wnt-signalling is known to mediate not only nephron induction, but also its orientation, cell proliferation, specification and differentiation [107, 110113]. Alterations in canonical and non-canonical Wnt-signalling are known to cause polycystic kidney diseases [114, 115]. Taken together, we suggest that Axin2 might impact kidney development by regulating Wnt-signalling as indicated, through its expression in the nephric duct and coelom epithelium. The Axin2 expression in the coelomic epithelium could possibly hint a role for Axin2 in the development of the derived Mullerian-duct that develops to form the female genitals. As male gonads develop from the nephric or Wolffian-duct, Axin2 might be involved in this developmental process as well.

0.7 cAxin2 expression in developing chicken eye

The chicken eye initially develops, as the prosencephalon out-pockets and the optic vesicle (ov) invaginates to the head mesenchyme. Axin2 in this process is expressed in the proximal layer of the bi-layered optic vesicle (ov)(Fig 8, HH 15: A.1, black arrow). By stage HH 16 the lens vesicle (lv) has formed from the ectoderm (Fig 8, B.1). Axin2 transcripts are still detectable mainly in the proximal layer of the optic cup (oc)(Fig 8, B.1, HH 17: C.1 black arrow). An additional expression in the subectodermal mesenchyme overlying the optic cup (oc) and surrounding the lens vesicle (lv) is established at stage HH 18 (Fig 8, D.1 black arrow). While the lens vesicle (lv) expresses little Axin2 in the inner lens epithelium (Fig 8, HH 19: E.1 and HH 20: F.1, F.2. F.3 red arrows), transcripts in the optic cup (oc) are found in both proximal and distal layer at the epithelial margins facing towards the vesicular space (Fig 8: HH 19: E.1 black arrow, HH 20: F.4 black arrow). In the following observed stages, the proximal layer of the optic cup (oc) has formed the retinal pigmented epithelium (rpe), whereas the distal layer differentiates into the retina [116]. Axin2 expression was found only in the lens (Fig 8, HH 24: H.3 red arrow), ectoderm and subectodermal mesenchyme covering the eye (Fig 8, HH 24: H.1 and H.2 black arrows). Regarding the formation of the optic nerve (on) and optic chiasm (och), Axin2 expression is observable in the approaching and fusing neuroepithelial layers (Fig 8, HH 25: I.1, HH 26: J.1, HH 27: K.1 black arrows). Further, Axin2 is expressed in the future cornea covering the eye (Fig 8, HH 25: I.1, HH 26: J.1, HH 27: K.2 black arrow, HH 28: L.1 and L.2 black arrows) and in the posterior lens epithelium (Fig 8, HH 26: J.2 and J.3; HH 27: K.1 and K.2 red and green arrows).

Fig 8. Axin2 transcripts in optic development.

Transversal sections through the developing eye in in-situ hybridized embryos. (A.1) HH 15: the primary ov expresses Axin2 in the proximal layer (black arrow). (B.1) HH 16: Axin2 expression in both layers of the bi-layered secondary oc. (C.1) HH 17: Axin2 expression in the proximal epithelium of the oc (black arrow). (D.1) HH 18: Axin2 expression in the proximal layer of the oc (red arrow). The ectoderm surrounding the invaginating, lv (black arrow) expresses Axin2. (D.2) HH 18: A section through the rostral most part of the oc, with highest expression rate in these margins. (E.1) HH 19: the proximal layer of the lv expresses Axin2 (red arrow) as well as the oc in both layers adjacent to the vesicular space (black arrow). (F.1, F.2, F.3, F.4) HH 20: expression in the ectoderm surrounding the eye, in the directly underlying mesenchyme, in the epithelium of the oc towards the lumen (F.1, black arrow; F.4, black arrow) and in the lens epithelium (F.1, F.2, F.3, red arrows). (HH 23: G.1; HH 24: H.1 and H.2, black arrows; HH 25: I.1; HH 26: J.1, J.2, J.3; HH 27: K.2, black arrow, HH 28: L.1, L.2, black arrows) Axin2 expression in the ectoderm and subectodermal mesenchyme (future cornea). (HH 25: I.1, black arrow; HH 26: J.1, black arrow, HH 27: K.1, black arrow) cAxin2 expression in the developing on and och. (H.3, HH 24; K.2, HH 27) expression of Axin2 in the developing lens (red and green arrows). ov-optic vesicle, oc-optic cup, lv-lens vesicle, on-optic nerve, och-optic chiasm, rpe-retinal pigmented epithelium.

Anteriorly expressed inhibitors of canonical Wnt signals are required for the initiation of the eye as described in zebrafish [117, 118]. Later, Wnt2b is expressed in the proliferative lens epithelium [119], retinal pigmented epithelium (rpe) and periphery of the optic cup [120122]. Further, Wnt3 and Wnt11 were found to be expressed in the outer layer of the chicken optic cup [122]. Wnt2b was described to be responsible for maintaining the proliferative state of neural progenitors in the retina in chick [123]. Previous studies have reported a depigmentation of the retinal pigmented epithelium (rpe) after disruption if Wnt2b signalling in the chicken eye [120]. Our observeded Axin2 expression in the lens overlaps with regions of increased cell proliferation, which express Wnt-ligands as well [122, 124, 125]. The chicken developing cornea and corneal stroma cells express Wnt3a and Wnt9b [126]. Interestingly, a subgroup of the disease familial adenomatous poliposis coli (FAP), which is caused by a truncation in APC or Axin2, the Gardner syndrome, includes a congenital hypertrophy of the rpe [127]. Additionally, some cases of tetra amelia, which is the result of homozygous Wnt3 mutations, exhibit optic malformations [128].


In the present study, we describe the expression pattern of avian Axin2 during embryonic development. We found a dynamic, temporally and spatially restricted expression pattern in many developing structures and tissues. In the early development of the chick, Axin2 was expressed in the primitive streak and underlying mesoderm, in the neural folds and in the head fold. It was additionally expressed during secondary neurulation in the tailbud mesenchyme. Here, the pre-somitic mesoderm as well transcribes Axin2. We were able to detect such expression in the posterior psm and during the maturation of the somites in its medial epithelium and in the dml. By this developmental stage, transcripts were also detectable in the brain and differentiating neural tube. In the developing limb a dynamic expression was found. Furthermore, we detected Axin2 mRNA in the nephric duct and coelomic epithelium. Regarding the head of the chicken embryo, Axin2 was expressed in branchial arches and sensory anlagen. Later in development, expression in feather buds, interdigital spaces, external ear and scleral ossicles on the eye was observed.

The expression of Axin2 in mice was previously found in the primitive streak, head folds, neural tube, branchial arches I and II (maxillary and mandibular arch), psm and dml, tailbud, limbs, kidney and brain [45, 78].

These findings are mainly consistent to the expression we found in the chick. Additionally, we were able to show Axin2 expression in the developing eye and in the otic vesicle. With this study we want to point out the often neglected impact of Axin2 in many Wnt-dependant developmental processes. While Wnt-ligands are extensively studied, investigating their regulation through Axin2 in the respective tissues might help understanding the interactions of different signalling factors.


We want to thank Houmani R. and Wulf S. for excellent technical assistance and Herrmann B. for conductin probe.

Author Contributions

  1. Conceptualization: GE MB BBS GMP.
  2. Data curation: GE.
  3. Formal analysis: GE GMP.
  4. Funding acquisition: BBS.
  5. Investigation: GE MB BBS GMP.
  6. Methodology: GE MB BBS GMP.
  7. Project administration: BBS.
  8. Resources: BBS.
  9. Supervision: BBS GMP.
  10. Visualization: GE.
  11. Writing – original draft: GE.
  12. Writing – review & editing: GE GMP.


  1. 1. Behrens J, Jerchow BA, Würtele M, Grimm J, Asbrand C, Wirtz R, et al. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β. Science. 1998;280(5363):596–599. pmid:9554852
  2. 2. Yamamoto H, Kishida S, Uochi T, Ikeda S, Koyama S, Asashima M, et al. Axil, a Member of the Axin Family, Interacts with Both Glycogen Synthase Kinase 3β and β-Catenin and Inhibits Axis Formation of Xenopus Embryos. Molecular and cellular biology. 1998;18(5):2867–2875. pmid:9566905
  3. 3. Kikuchi A. Roles of Axin in the Wnt signalling pathway. Cellular signalling. 1999;11(11):777–788. pmid:10617280
  4. 4. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. The EMBO journal. 1998;17(5):1371–1384. pmid:9482734
  5. 5. Nakamura T, Hamada F, Ishidate T, Anai Ki, Kawahara K, Toyoshima K, et al. Axin, an inhibitor of the Wnt signalling pathway, interacts with β-catenin, GSK-3β and APC and reduces the β-catenin level. Genes to Cells. 1998;3(6):395–403. pmid:9734785
  6. 6. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P. Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β. Current Biology. 1998;8(10):573–581. pmid:9601641
  7. 7. Kishida S, Yamamoto H, Hino Si, Ikeda S, Kishida M, Kikuchi A. DIX domains of Dvl and Axin are necessary for protein interactions and their ability to regulate β-catenin stability. Molecular and cellular biology. 1999;19(6):4414–4422. pmid:10330181
  8. 8. Luo W, Lin SC. Axin: a master scaffold for multiple signaling pathways. Neurosignals. 2004;13(3):99–113. pmid:15067197
  9. 9. Hsu W, Zeng L, Costantini F. Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. Journal of Biological Chemistry. 1999;274(6):3439–3445. pmid:9920888
  10. 10. Kishida M, Koyama S, Kishida S, Matsubara K, Nakashima S, Higano K, et al. Axin prevents Wnt-3a-induced accumulation of β-catenin. Oncogene. 1999;18(4). pmid:10023673
  11. 11. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL, et al. The mouse Fusedlocus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell. 1997;90(1):181–192. pmid:9230313
  12. 12. Sakanaka C, Weiss JB, Williams LT. Bridging of β-catenin and glycogen synthase kinase-3β by axin and inhibition of β-catenin-mediated transcription. Proceedings of the National Academy of Sciences. 1998;95(6):3020–3023. pmid:9501208
  13. 13. Kohn AD, Moon RT. Wnt and calcium signaling: β-catenin-independent pathways. Cell calcium. 2005;38(3):439–446. pmid:16099039
  14. 14. Katoh M. WNT/PCP signaling pathway and human cancer (review). Oncology reports. 2005;14(6):1583–1588. pmid:16273260
  15. 15. Barrow JR. Wnt/PCP signaling: a veritable polar star in establishing patterns of polarity in embryonic tissues. In: Seminars in cell & developmental biology. vol. 17. Elsevier; 2006. p. 185–193. pmid:16765615
  16. 16. Komiya Y, Habas R. Wnt signal transduction pathways. Organogenesis. 2008;4(2):68–75. pmid:19279717
  17. 17. Semenov MV, Habas R, MacDonald BT, He X. SnapShot: noncanonical Wnt signaling pathways. Cell. 2007;131(7):1378. pmid:18160045
  18. 18. Grumolato L, Liu G, Mong P, Mudbhary R, Biswas R, Arroyave R, et al. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes & development. 2010;24(22):2517–2530. pmid:21078818
  19. 19. van Amerongen R, Fuerer C, Mizutani M, Nusse R. Wnt5a can both activate and repress Wnt/β-catenin signaling during mouse embryonic development. Developmental biology. 2012;369(1):101–114. pmid:22771246
  20. 20. Cha SW, Tadjuidje E, Tao Q, Wylie C, Heasman J. Wnt5a and Wnt11 interact in a maternal Dkk1-regulated fashion to activate both canonical and non-canonical signaling in Xenopus axis formation. Development. 2008;135(22):3719–3729. pmid:18927149
  21. 21. Kestler HA, Kühl M. From individual Wnt pathways towards a Wnt signalling network. Philosophical Transactions of the Royal Society of London B: Biological Sciences. 2008;363(1495):1333–1347. pmid:18192173
  22. 22. Tao Q, Yokota C, Puck H, Kofron M, Birsoy B, Yan D, et al. Maternal wnt11 activates the canonical wnt signaling pathway required for axis formation in Xenopus embryos. Cell. 2005;120(6):857–871. pmid:15797385
  23. 23. Daniels DL, Weis WI. β-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nature structural & molecular biology. 2005;12(4):364–371. pmid:15768032
  24. 24. Willert K, Jones KA. Wnt signaling: is the party in the nucleus? Genes & development. 2006;20(11):1394–1404. pmid:16751178
  25. 25. Kitagawa M, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K, et al. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of β-catenin. The EMBO journal. 1999;18(9):2401–2410. pmid:10228155
  26. 26. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. β-catenin is a target for the ubiquitin–proteasome pathway. The EMBO journal. 1997;16(13):3797–3804. pmid:9233789
  27. 27. Huang H, He X. Wnt/β-catenin signaling: new (and old) players and new insights. Current opinion in cell biology. 2008;20(2):119–125. pmid:18339531
  28. 28. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science. 1996;272(5264):1023–1026. pmid:8638126
  29. 29. Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R, et al. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature. 2005;438(7069):873–877. pmid:16341017
  30. 30. Jho Eh, Lomvardas S, Costantini F. A GSK3β phosphorylation site in axin modulates interaction with β-catenin and Tcf-mediated gene expression. Biochemical and biophysical research communications. 1999;266(1):28–35. pmid:10581160
  31. 31. Kishida S, Yamamoto H, Ikeda S, Kishida M, Sakamoto I, Koyama S, et al. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin. Journal of Biological Chemistry. 1998;273(18):10823–10826. pmid:9556553
  32. 32. Fagotto F, Jho Eh, Zeng L, Kurth T, Joos T, Kaufmann C, et al. Domains of axin involved in protein–protein interactions, Wnt pathway inhibition, and intracellular localization. The Journal of cell biology. 1999;145(4):741–756. pmid:10330403
  33. 33. Hinoi T, Yamamoto H, Kishida M, Takada S, Kishida S, Kikuchi A. Complex formation of adenomatous polyposis coli gene product and Axin facilitates glycogen synthase kinase-3β-dependent phosphorylation of β-catenin and down-regulates β-catenin. Journal of Biological Chemistry. 2000;275(44):34399–34406. pmid:10906131
  34. 34. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781–810. pmid:15473860
  35. 35. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, et al. LDL-receptor-related proteins in Wnt signal transduction. Nature. 2000;407(6803):530–535. pmid:11029007
  36. 36. He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling: arrows point the way. Development. 2004;131(8):1663–1677. pmid:15084453
  37. 37. Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127(3):469–480. pmid:17081971
  38. 38. Tamai K, Zeng X, Liu C, Zhang X, Harada Y, Chang Z, et al. A mechanism for Wnt coreceptor activation. Molecular cell. 2004;13(1):149–156. pmid:14731402
  39. 39. Davidson G, Wu W, Shen J, Bilic J, Fenger U, Stannek P, et al. Casein kinase 1 γ couples Wnt receptor activation to cytoplasmic signal transduction. Nature. 2005;438(7069):867–872. pmid:16341016
  40. 40. Liu X, Rubin JS, Kimmel AR. Rapid, Wnt-induced changes in GSK3β associations that regulate β-catenin stabilization are mediated by Gα proteins. Current Biology. 2005;15(22):1989–1997. pmid:16303557
  41. 41. Schwarz-Romond T, Metcalfe C, Bienz M. Dynamic recruitment of axin by Dishevelled protein assemblies. Journal of cell science. 2007;120(14):2402–2412. pmid:17606995
  42. 42. Willert K, Shibamoto S, Nusse R. Wnt-induced dephosphorylation of axin releases β-catenin from the axin complex. Genes & development. 1999;13(14):1768–1773. pmid:10421629
  43. 43. MacDonald BT, Tamai K, He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Developmental cell. 2009;17(1):9–26. pmid:19619488
  44. 44. Bilić J, Huang YL, Davidson G, Zimmermann T, Cruciat CM, Bienz M, et al. Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science. 2007;316(5831):1619–1622. pmid:17569865
  45. 45. Jho Eh, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Molecular and cellular biology. 2002;22(4):1172–1183. pmid:11809808
  46. 46. Popperl H, Schmidt C, Wilson V, Hume C, Dodd J, Krumlauf R, et al. Misexpression of Cwnt8C in the mouse induces an ectopic embryonic axis and causes a truncation of the anterior neuroectoderm. Development. 1997;124(15):2997–3005. pmid:9247341
  47. 47. McMahon AP, Moon RT. Ectopic expression of the proto-oncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis. Cell. 1989;58(6):1075–1084. pmid:2673541
  48. 48. Huelsken J, Vogel R, Brinkmann V, Erdmann B, Birchmeier C, Birchmeier W. Requirement for β-catenin in anterior-posterior axis formation in mice. The Journal of cell biology. 2000;148(3):567–578. pmid:10662781
  49. 49. Grigoryan T, Wend P, Klaus A, Birchmeier W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss-and gain-of-function mutations of β-catenin in mice. Genes & development. 2008;22(17):2308–2341. pmid:18765787
  50. 50. Aulehla A, Wiegraebe W, Baubet V, Wahl MB, Deng C, Taketo M, et al. A β-catenin gradient links the clock and wavefront systems in mouse embryo segmentation. Nature cell biology. 2008;10(2):186–193. pmid:18157121
  51. 51. Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012;149(6):1192–1205. pmid:22682243
  52. 52. Polakis P. The many ways of Wnt in cancer. Current opinion in genetics & development. 2007;17(1):45–51. pmid:17208432
  53. 53. Perry WL, Vasicek TJ, Lee JJ, Rossi JM, Zeng L, Zhang T, et al. Phenotypic and molecular analysis of a transgenic insertional allele of the mouse Fused locus. Genetics. 1995;141(1):321–332. pmid:8536979
  54. 54. Chia IV, Costantini F. Mouse axin and axin2/conductin proteins are functionally equivalent in vivo. Molecular and cellular biology. 2005;25(11):4371–4376. pmid:15899843
  55. 55. Yu HMI, Jerchow B, Sheu TJ, Liu B, Costantini F, Puzas JE, et al. The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development. 2005;132(8):1995–2005. pmid:15790973
  56. 56. Lohi M, Tucker AS, Sharpe PT. Expression of Axin2 indicates a role for canonical Wnt signaling in development of the crown and root during pre-and postnatal tooth development. Developmental Dynamics. 2010;239(1):160–167. pmid:19653310
  57. 57. Lammi L, Arte S, Somer M, Järvinen H, Lahermo P, Thesleff I, et al. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. The American Journal of Human Genetics. 2004;74(5):1043–1050. pmid:15042511
  58. 58. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, et al. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Molecular and cellular biology. 2002;22(4):1184–1193. pmid:11809809
  59. 59. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nature genetics. 2000;24(3):245–250. pmid:10700176
  60. 60. Wu R, Zhai Y, Fearon ER, Cho KR. Diverse mechanisms of β-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer research. 2001;61(22):8247–8255. pmid:11719457
  61. 61. Dahmen R, Koch A, Denkhaus D, Tonn J, Sörensen N, Berthold F, et al. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer research. 2001;61(19):7039–7043. pmid:11585731
  62. 62. Polakis P. The adenomatous polyposis coli (APC) tumor suppressor. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 1997;1332(3):F127–F147.
  63. 63. Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, et al. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumors. Proceedings of the National Academy of Sciences. 2001;98(26):14973–14978. pmid:11752446
  64. 64. Lee E, Salic A, Krüger R, Heinrich R, Kirschner MW. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol. 2003;1(1):e10. pmid:14551908
  65. 65. Hamburger V, Hamilton HL. A series of normal stages in the development of the chick embryo. Journal of morphology. 1951;88(1):49–92. pmid:24539719
  66. 66. Nieto MA, Patel K, Wilkinson DG. In situ hybridization analysis of chick embryos in whole mount and tissue sections. methods in cell biology. 1996;51:219. pmid:8722478
  67. 67. Hikasa H, Sokol SY. Wnt signaling in vertebrate axis specification. Cold Spring Harbor perspectives in biology. 2013;5(1):a007955. pmid:22914799
  68. 68. Durston A. Time, space and the vertebrate body axis. In: Seminars in cell & developmental biology. vol. 42. Elsevier; 2015. p. 66–77. pmid:26003049
  69. 69. Takada S, Stark KL, Shea MJ, Vassileva G, McMahon JA, McMahon AP. Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes & development. 1994;8(2):174–189. pmid:8299937
  70. 70. Cunningham TJ, Kumar S, Yamaguchi TP, Duester G. Wnt8a and Wnt3a cooperate in the axial stem cell niche to promote mammalian body axis extension. Developmental Dynamics. 2015;244(6):797–807. pmid:25809880
  71. 71. Niehrs C. Regionally specific induction by the Spemann–Mangold organizer. Nature Reviews Genetics. 2004;5(6):425–434. pmid:15153995
  72. 72. Thisse B, Wright CV, Thisse C. Activin-and Nodal-related factors control antero–posterior patterning of the zebrafish embryo. Nature. 2000;403(6768):425–428. pmid:10667793
  73. 73. Xu PF, Houssin N, Ferri-Lagneau KF, Thisse B, Thisse C. Construction of a vertebrate embryo from two opposing morphogen gradients. Science. 2014;344(6179):87–89. pmid:24700857
  74. 74. Glinka A, Wu W, Onichtchouk D, Blumenstock C, Niehrs C. Head induction by simultaneous repression of Bmp and Wnt signalling in Xenopus. Nature. 1997;389(6650):517–519. pmid:9333244
  75. 75. Yasuo H, Lemaire P. Role of Goosecoid, Xnot and Wnt antagonists in the maintenance of the notochord genetic programme in Xenopus gastrulae. Development. 2001;128(19):3783–3793. pmid:11585804
  76. 76. Gluecksohn-Schoenheimer S. The effects of a lethal mutation responsible for duplications and twinning in mouse embryos. Journal of Experimental Zoology. 1949;110(1):47–76. pmid:18113441
  77. 77. Chapman SC, Brown R, Lees L, Schoenwolf GC, Lumsden A. Expression analysis of chick Wnt and frizzled genes and selected inhibitors in early chick patterning. Developmental dynamics. 2004;229(3):668–676. pmid:14991722
  78. 78. Aulehla A, Wehrle C, Brand-Saberi B, Kemler R, Gossler A, Kanzler B, et al. Wnt3a plays a major role in the segmentation clock controlling somitogenesis. Developmental cell. 2003;4(3):395–406. pmid:12636920
  79. 79. Marcelle C, Stark MR, Bronner-Fraser M. Coordinate actions of BMPs, Wnts, Shh and noggin mediate patterning of the dorsal somite. Development. 1997;124(20):3955–3963. pmid:9374393
  80. 80. Hirsinger E, Duprez D, Jouve C, Malapert P, Cooke J, Pourquié O. Noggin acts downstream of Wnt and Sonic Hedgehog to antagonize BMP4 in avian somite patterning. Development. 1997;124(22):4605–4614. pmid:9409677
  81. 81. Ikeya M, Takada S. Wnt signaling from the dorsal neural tube is required for the formation of the medial dermomyotome. Development. 1998;125(24):4969–4976. pmid:9811581
  82. 82. Schubert FR, Mootoosamy RC, Walters EH, Graham A, Tumiotto L, Münsterberg AE, et al. Wnt6 marks sites of epithelial transformations in the chick embryo. Mechanisms of development. 2002;114(1):143–148. pmid:12175501
  83. 83. Geetha-Loganathan P, Nimmagadda S, Huang R, Christ B, Scaal M. Regulation of ectodermal Wnt6 expression by the neural tube is transduced by dermomyotomal Wnt11: a mechanism of dermomyotomal lip sustainment. Development. 2006;133(15):2897–2904. pmid:16818447
  84. 84. Chesnutt C, Burrus LW, Brown AM, Niswander L. Coordinate regulation of neural tube patterning and proliferation by TGFβ and WNT activity. Developmental biology. 2004;274(2):334–347. pmid:15385163
  85. 85. Wilson L, Maden M. The mechanisms of dorsoventral patterning in the vertebrate neural tube. Developmental biology. 2005;282(1):1–13. pmid:15936325
  86. 86. Hollyday M, McMahon JA, McMahon AP. Wnt expression patterns in chick embryo nervous system. Mechanisms of development. 1995;52(1):9–25. pmid:7577679
  87. 87. Megason SG, McMahon AP. A mitogen gradient of dorsal midline Wnts organizes growth in the CNS. Development. 2002;129(9):2087–2098. pmid:11959819
  88. 88. Alvarez-Medina R, Cayuso J, Okubo T, Takada S, Martí E. Wnt canonical pathway restricts graded Shh/Gli patterning activity through the regulation of Gli3 expression. Development. 2008;135(2):237–247. pmid:18057099
  89. 89. Augustine KA, Liu ET, Sadler T. Interactions of Wnt-1 and Wnt-3a are essential for neural tube patterning. Teratology. 1995;51(2):107–119. pmid:7660319
  90. 90. Yu W, McDonnell K, Taketo MM, Bai CB. Wnt signaling determines ventral spinal cord cell fates in a time-dependent manner. Development. 2008;135(22):3687–3696. pmid:18927156
  91. 91. Saunders JW. The proximo-distal sequence of origin of the parts of the chick wing and the role of the ectoderm. Journal of Experimental Zoology. 1948;108(3):363–403. pmid:18882505
  92. 92. Kawakami Y, Capdevila J, Büscher D, Itoh T, Esteban CR, Belmonte JCI. WNT signals control FGF-dependent limb initiation and AER induction in the chick embryo. Cell. 2001;104(6):891–900. pmid:11290326
  93. 93. Johnson RL, Tabin CJ. Molecular models for vertebrate limb development. Cell. 1997;90(6):979–990. pmid:9323126
  94. 94. Parr BA, Shea MJ, Vassileva G, McMahon AP. Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. Development. 1993;119(1):247–261. pmid:8275860
  95. 95. Dealy CN, Roth A, Ferrari D, Brown AM, Kosher RA. Wnt-5a and Wnt-7a are expressed in the developing chick limb bud in a manner suggesting roles in pattern formation along the proximodistal and dorsoventral axes. Mechanisms of development. 1993;43(2):175–186. pmid:8297789
  96. 96. Kengaku M, Capdevila J, Rodriguez-Esteban C, De La Peña J, Johnson RL, Belmonte JCI, et al. Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud. Science. 1998;280(5367):1274–1277. pmid:9596583
  97. 97. Church VL, Francis-West P. Wnt signalling during limb development. International Journal of Developmental Biology. 2002;46(7):927–936. pmid:12455630
  98. 98. Farrell ER, Münsterberg AE. csal1 is controlled by a combination of FGF and Wnt signals in developing limb buds. Developmental biology. 2000;225(2):447–458. pmid:10985862
  99. 99. ten Berge D, Brugmann SA, Helms JA, Nusse R. Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development. Development. 2008;135(19):3247–3257. pmid:18776145
  100. 100. Saxén L, Sariola H. Early organogenesis of the kidney. Pediatric nephrology. 1987;1(3):385–392. pmid:3153305
  101. 101. Carroll TJ, Park JS, Hayashi S, Majumdar A, McMahon AP. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Developmental cell. 2005;9(2):283–292. pmid:16054034
  102. 102. Park JS, Valerius MT, McMahon AP. Wnt/β-catenin signaling regulates nephron induction during mouse kidney development. Development. 2007;134(13):2533–2539. pmid:17537789
  103. 103. Stark K, Vainio S, Vassileva G, McMahon AP. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature. 1994;372(6507):679–683. pmid:7990960
  104. 104. Karner CM, Chirumamilla R, Aoki S, Igarashi P, Wallingford JB, Carroll TJ. Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis. Nature genetics. 2009;41(7):793–799. pmid:19543268
  105. 105. Burn S, Webb A, Berry R, Davies J, Ferrer-Vaquer A, Hadjantonakis A, et al. Calcium/NFAT signalling promotes early nephrogenesis. Developmental biology. 2011;352(2):288–298. pmid:21295565
  106. 106. Tanigawa S, Wang H, Yang Y, Sharma N, Tarasova N, Ajima R, et al. Wnt4 induces nephronic tubules in metanephric mesenchyme by a non-canonical mechanism. Developmental biology. 2011;352(1):58–69. pmid:21256838
  107. 107. Mccoy KE, Zhou X, Vize PD. Non-canonical wnt signals antagonize and canonical wnt signals promote cell proliferation in early kidney development. Developmental Dynamics. 2011;240(6):1558–1566. pmid:21465621
  108. 108. Simons M, Mlodzik M. Planar cell polarity signaling: from fly development to human disease. Annual review of genetics. 2008;42:517. pmid:18710302
  109. 109. Simons M, Gloy J, Ganner A, Bullerkotte A, Bashkurov M, Krönig C, et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nature genetics. 2005;37(5):537–543. pmid:15852005
  110. 110. Karner CM, Das A, Ma Z, Self M, Chen C, Lum L, et al. Canonical Wnt9b signaling balances progenitor cell expansion and differentiation during kidney development. Development. 2011;138(7):1247–1257. pmid:21350016
  111. 111. Iglesias DM, Hueber PA, Chu L, Campbell R, Patenaude AM, Dziarmaga AJ, et al. Canonical WNT signaling during kidney development. American Journal of Physiology-Renal Physiology. 2007;293(2):F494–F500. pmid:17494089
  112. 112. Lyons JP, Miller RK, Zhou X, Weidinger G, Deroo T, Denayer T, et al. Requirement of Wnt/β-catenin signaling in pronephric kidney development. Mechanisms of development. 2009;126(3):142–159. pmid:19100832
  113. 113. Schneider J, Arraf AA, Grinstein M, Yelin R, Schultheiss TM. Wnt signaling orients the proximal-distal axis of chick kidney nephrons. Development. 2015;142(15):2686–2695. pmid:26116665
  114. 114. Lancaster MA, Gleeson JG. Cystic kidney disease: the role of Wnt signaling. Trends in molecular medicine. 2010;16(8):349–360. pmid:20576469
  115. 115. Luyten A, Su X, Gondela S, Chen Y, Rompani S, Takakura A, et al. Aberrant regulation of planar cell polarity in polycystic kidney disease. Journal of the American Society of Nephrology. 2010;21(9):1521–1532. pmid:20705705
  116. 116. Chow RL, Lang RA. Early eye development in vertebrates. Annual review of cell and developmental biology. 2001;17(1):255–296. pmid:11687490
  117. 117. Heisenberg CP, Houart C, Take-uchi M, Rauch GJ, Young N, Coutinho P, et al. A mutation in the Gsk3–binding domain of zebrafish Masterblind/Axin1 leads to a fate transformation of telencephalon and eyes to diencephalon. Genes & Development. 2001;15(11):1427–1434. pmid:11390362
  118. 118. Kim CH, Oda T, Itoh M, Jiang D, Artinger KB, Chandrasekharappa SC, et al. Repressor activity of Headless/Tcf3 is essential for vertebrate head formation. Nature. 2000;407(6806):913–916. pmid:11057671
  119. 119. Jasoni C, Hendrickson A, Roelink H. Analysis of chicken Wnt-13 expression demonstrates coincidence with cell division in the developing eye and is consistent with a role in induction. Developmental dynamics. 1999;215(3):215–224. pmid:10398532
  120. 120. Cho SH, Cepko CL. Wnt2b/β-catenin-mediated canonical Wnt signaling determines the peripheral fates of the chick eye. Development. 2006;133(16):3167–3177. pmid:16854977
  121. 121. Kubo F, Takeichi M, Nakagawa S. Wnt2b controls retinal cell differentiation at the ciliary marginal zone. Development. 2003;130(3):587–598. pmid:12490564
  122. 122. Jin EJ, Burrus LW, Erickson CA. The expression patterns of Wnts and their antagonists during avian eye development. Mechanisms of development. 2002;116(1):173–176. pmid:12128219
  123. 123. Kubo F, Takeichi M, Nakagawa S. Wnt2b inhibits differentiation of retinal progenitor cells in the absence of Notch activity by downregulating the expression of proneural genes. Development. 2005;132(12):2759–2770. pmid:15901663
  124. 124. Jidigam VK, Gunhaga L. Development of cranial placodes: insights from studies in chick. Development, growth & differentiation. 2013;55(1):79–95. pmid:23278869
  125. 125. Grocott T, Johnson S, Bailey AP, Streit A. Neural crest cells organize the eye via TGF-β and canonical Wnt signalling. Nature communications. 2011;2:265. pmid:21468017
  126. 126. Fokina VM, Frolova EI. Expression patterns of Wnt genes during development of an anterior part of the chicken eye. Developmental dynamics. 2006;235(2):496–505. pmid:16258938
  127. 127. Traboulsi EI. Ocular manifestations of familial adenomatous polyposis (Gardner syndrome). Ophthalmology clinics of North America. 2005;18(1):163–6. pmid:15763201
  128. 128. Niemann S, Zhao C, Pascu F, Stahl U, Aulepp U, Niswander L, et al. Homozygous WNT3 mutation causes tetra-amelia in a large consanguineous family. The American Journal of Human Genetics. 2004;74(3):558–563. pmid:14872406